FDA pharmacologic class
Potassium Channel Blocker
2 medicines are in FDA's class of potassium channel blockers: dalfampridine (Ampyra) and amifampridine (Firdapse). 1 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is dalfampridine er 10 mg tablet at $0.399 per tablet (NADAC).
Which medicines are potassium channel blocker?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Dalfampridine | Ampyra | 9 labelers | $0.399 per tablet 10 mg tablet | No | No current entry | 0 |
| Amifampridine | Firdapse | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price